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Right-side-up and up-side-down NK-cell receptors
Recent cDNA cloning of the receptors on human natural killer cells for
MHC class I molecules reveals that human and mouse receptors have
inverted structural orientations. Are there two distinct receptor systems?
Two types of cytotoxic lymphocyte, T and natural killer
(NK) cells, provide host defence against tumors and
invading pathogens. In general, both types of lymphocyte
use similar effector mechanisms to kill their cellular targets
and they also produce cytokines that regulate acquired
immune responses. Indeed, these cells appear to share an
immediate common progenitor cell. However, emerging
data indicate that T and NK cells use different receptors
to discriminate between the targets they kill and those
they do not [1,2].
Each T cell displays a unique (clonotypic) antigen-spe-
cific T-cell receptor (TCR) that is produced by physical
recombination of TCR genes. Most cytotoxic T cells
recognize foreign peptides presented by major histocom-
patibility complex (MHC) class I molecules on target
cells. This recognition triggers T-cell activation and path-
ways that lead to the lysis of target cells. However, NK
cells do not express the TCR, nor do they require MHC
class I molecules on targets in order to kill them. In fact,
MHC class I molecules on target cells inhibit NK-cell
activation [3]. As a teleological explanation, Karre pro-
posed [3] the 'missing-self' hypothesis to account for this
fundamental difference between NK and T cells. Accord-
ing to this hypothesis, T cells search for 'presence of for-
eign' whereas NK cells survey tissues for 'absence of self',
as indicated by aberrant or absent expression of MHC
class I molecules - as might occur in tumorigenesis or
viral infection. Then NK cells are released from the
chronic inhibitory influence of MHC class I molecules
and lyse the target cell.
NK cells can be induced to kill targets through several
'activation' receptors. Although putative receptors respon-
sible for natural killing have not been identified in
humans, NKR-P1 appears to be such a receptor used
by rodent NK cells in recognizing some targets. Rodent
NK cells may be activated by binding of NKR-P1 to
carbohydrate determinants on target cells [4]. NK cells
also mediate antibody-dependent cellular cytotoxicity,
through FcyRIIIA receptors that bind to the Fc portions
of IgG antibodies on coated targets [5]. To explain the
inhibition of NK cells by MHC class I molecules, one
general working model suggests that NK cells express
receptors that specifically bind MHC class I molecules
and then transmit 'negative' signals, blocking the activa-
tion that would otherwise occur if activation receptors
were engaged (Fig. 1) [6].
Functional and serologic analyses previously revealed
several candidate human receptors for MHC class I
molecules that are constitutively expressed by overlap-
ping subsets of NK cells [7]. Of these, the p58 molecules
are monomers (55-58 kDa; 38 kDa when deglycosy-
lated) that bear epitopes recognized by the monoclonal
antibodies GL183 or EB6; they dictate NK-cell inhibi-
tion by HLA-Cw3- or HLA-Cw4-related MHC mol-
ecules, respectively. The HP3E4 monoclonal antibody
appears to recognize a molecule similar to that seen
by EB6 [8]. Although the NKB1 molecule is larger
(70 kDa; 50 kDa when deglycosylated) and recognizes
certain HLA-B molecules [9], its expression and func-
tional characteristics are similar to p5 8 , suggesting that
Fig. 1. The activation and inhibitory
receptor model for natural killing. The
'activation' type of receptor is capable of
binding putative target-cell ligands, lead-
ing to activation of the NK cell; one such
receptor is the rodent NKR-P1 molecule,
which binds carbohydrate determinants.
The 'inhibitory' receptor is capable of
binding MHC class I molecules on the
target cell and then delivers inhibitory
signals that block activation, probably
downstream of early activation events.
Recent cDNA cloning of the human
receptors has yielded distinct differences
when compared to mouse Ly-49. Multi-
ple forms of activation and inhibitory
receptors, each with potentially different
or overlapping specificities, may be
expressed by a single NK cell; for
clarity, only one of each is shown. Cross-
linking of the receptors is presumably
required; this is also not shown.
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they may be related. Moreover, both p58 and NKB1
molecules appear to recognize corresponding regions on
their MHC class I ligands [7,9,10].
In a major advance towards understanding the molecular
basis for NK-cell specificity, two groups used different
strategies to clone cDNAs encoding human NK-cell
receptors, termed p58 and NKAT, respectively [11,12].
Both approaches yielded similar sequences that encode
novel type I integral membrane proteins with immuno-
globulin-like domains belonging to the C2 set, indicating
membership of the immunoglobulin superfamily (Fig. 2).
At least seven cross-hybridizing transcripts have been
identified that have more than 90 % amino-acid identity.
The cl-6 and NKAT-2 sequences are identical and encode
the GL183 epitope, whereas cl-42 and NKAT-1 are iden-
tical and encode the EB6 and HP3E4 epitopes (Fig. 2).
Expression of the different isoforms could be correlated
with the MHC (HLA-C) specificity of NK-cell clones
[12]. The NKAT-3 and NKAT-4 molecules contain an
additional immunoglobulin-like domain, and thus are
larger polypeptides; either may be identical to the NKB1
molecule (Fig. 2). Overall, the p58/NKAT sequences bear
differences that are scattered throughout their sequences,
and Southern blots reveal several bands that cross-hybri-
dize. Early evidence suggests that these sequence differ-
ences are not due to allelic polymorphism but reflect a
family of highly related genes within an individual. Thus,
cDNA cloning will facilitate further analysis, including
assessment of whether there is a direct interaction between
p58/NKAT and MHC class I molecules.
gene complex (NKC) on distal mouse chromosome 6
[14]. Also residing in this region are the genes for the
mouse NKR-P1 family and CD69 [15,16], which
encode molecules structurally similar to Ly-49 (type II
orientation, disulfide-linked dimer, with C-type lectin
homology). The human CD69 gene has been localized
to a syntenic region on human chromosome 12p13, as
have the genes for several human NK-cell-specific mol-
ecules, including human NKR-P1 [17], and the NKG2
family [18]. Although the function of human NKR-P1
and NKG2 molecules is still uncertain, CD94, another
molecule structurally related to Ly-49, is of particular
interest because it appears to be an inhibitory NK-cell
receptor for certain HLA-B molecules in some experi-
mental systems [19]. However, CD94 does not appear
to be the human Ly-49 homolog by sequence alignment
(L. Lanier, personal communication).
The DNA sequences of gene families within the NKC
are not related to each other, and even when homologs
are known in both species, it is not always possible to use
DNA probes for cross-species hybridization. The NKC
may therefore contain gene families that have not yet
There are significant similarities between human and
mouse NK-cell receptors for MHC class I molecules
(Table 1). Like the human receptors, the mouse Ly-49A
receptor is selectively expressed on an NK-cell subset.
In cytolytic and cell-binding assays, and in vivo expres-
sion analysis, the Ly-49A receptor binds specific MHC
class I molecules and then appears to deliver inhibitory
signals that override activation of natural killing, anti-
body-dependent cellular cytotoxicity, and other trigger-
ing pathways [13]. Like the human receptors, Ly-49A
belongs to a family of highly related genes that also
appear to bind MHC class I molecules and are expressed
by overlapping NK-cell subsets. In contrast to human
p58/NKAT molecules, however, the Ly-49 family of
molecules have an inverted orientation; they are type
II integral membrane proteins (Fig. 2). Moreover, they
are expressed as disulfide-linked homodimers with exter-
nal carboxy-terminal domains bearing homology to
the C-type lectin superfamily. The differences between
human and mouse NK-cell receptors suggest that each
species may have evolved structurally distinct molecules
to subserve identical functions.
It remains possible, however, that the corresponding
homologs of p58/NKAT and Ly-49 exist but have not
yet been identified. The genes encoding the Ly-49 fam-
ily are clustered in a genomic region termed the NK
Fig. 2. Human p58/NKAT and mouse Ly-49 receptors. The cl-42
and cl-6 sequences are identical to NKAT-1 and NKAT-2, respec-
tively, by sequence alignment (not shown) using the Pileup algo-
rithm in the GCG software package 1331. The NKAT-3 and
NKAT-4 molecules may express the NKB1 epitope.
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Ly-49-heterozygous mice might thus display a reasonable
repertoire of Ly-49 molecules if such molecules could be
equally expressed. Recent work from the Raulet group
[20], however, indicates that the expression of Ly-49
molecules is more limited than expected. Surprisingly, F1
hybrid mice express only one allelic form of Ly-49A
or Ly-49C, indicating that the expressed repertoire of
Ly-49 molecules is subject to allelic exclusion. Prelimi-
nary studies by others verify these results [21]. These
findings have significant implications for understanding
the role of NK cells in rejection of bone marrow grafts,
in which Ly-49 family members are implicated [22].
In contrast, early studies indicate that the human p58/
NKAT receptors have limited allelic polymorphism
[11,12], consistent with the concept that they are not the
functional homologs of Ly-49 molecules.
been identified in both species. For example, the mouse
homologs of NKG2 and CD94 have not yet been iden-
tified, but presumably they are encoded by the mouse
NKC. On the other hand, the p58/NKAT genes are
located on human chromosome 19 [11,12]. So, itmay be
necessary to use genetic analysis to identify the corre-
sponding homologs of Ly-49 and p58/NKAT. Thus,
emerging data seem to indicate significant 'redundancy'
among NK-cell receptors, and support the view that
there are two types of receptor for MHC class I mol-
ecules, resembling the immunoglobulin superfamily and
C-type lectins, respectively.
Are these truly redundant receptor systems, in which one
can totally take the place of the other? According to the
missing-self hypothesis, these receptors would be indis-
pensable for discrimination of self and non-self. Redun-
dancy may be useful to thwart pathogen mutations that
would otherwise subvert one but not the other system, or
to prevent an autoimmune situation. On the other hand,
significant differences between the receptor systems may
be indicative of heretofore unrecognized cooperativity,
or distinct functions.
There appear to be multiple alleles for each Ly-49 family
member, and each may have a different specificity [13].
Both human and mouse receptors interact with the pep-
tide-binding domains of MHC class I molecules, suggest-
ing that peptides may influence the interaction between
receptor and MHC class I molecules. Experiments have
been performed with NK-sensitive cells that lack the
transporters for antigen-processing (TAPs) and so do not
have normal MHC class I expression. When these cells
were loaded with exogenous peptides to stabilize MHC
class I molecules on their surfaces, human NK-cell clones
demonstrated specificity for the loaded peptide, suggest-
ing that p58/NKAT molecules may bind MHC-bound
peptides directly [23]. In contrast, Ly-49A receptors seem
to interact with their MHC class I ligands regardless of
loaded peptide [24], implying a more general role for
peptides in either stabilizing adequate expression of, or
inducing conformational determinants on, MHC class I
molecules. Ly-49A is also capable of binding carbohy-
drates [25]. Although it is not yet clear whether Ly-49A
binds carbohydrate determinants on MHC class I or
bound peptides, NKB1 binding is not carbohydrate-
dependent [9]. These findings indicate differences in the
fine specificities of these receptors.
If these differences are insignificant, the receptor systems
may be truly redundant. On the other hand, the differ-
ences may be important, implying that each receptor
might contribute to the function of the other. It is there-
fore possible that these molecules are co-receptors for
MHC class I molecules, generally analogous to MHC
class I-specific TCR and the CD8 co-receptor, which
bind to different domains on MHC class I molecules [26].
Alternatively, the true physiological functions of the NK-
cell receptors may not have been fully elucidated in stud-
ies performed thus far. Clearly further analysis of each
receptor system should provide insights into the other.
The NK-cell receptors that recognize MHC class I mol-
ecules presumably prevent activation through other NK-
cell receptors by transducing 'negative' biochemical
signals. Significantly, the p58/NKAT molecules contain a
cytoplasmic sequence [11,12] similar to the immune
receptor tyrosine-based activation motif (ITAM) [27]
that couples activation receptors to intracellular protein
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tyrosine kinases. However, the p58/NKAT motifs are
either truncated or have a longer spacer than other
ITAMs, suggesting that they may play a role in inhibiting
NK-cell activity by interrupting the normal association of
tyrosine kinases with activation receptors. On the other
hand, p58 molecules have been shown by antibody-cross-
linking to be capable of stimulating signal transduction
events [7,28], and they may be associated with tyrosine
kinases [7], perhaps through these same ITAM motifs. As
natural killing signal transduction pathways are poorly
understood, progress in understanding negative signals
will require parallel delineation of the activation pathways.
Given the detailed knowledge of T-cell activation path-
ways [29], the recent finding that p58 or NKB1 prevents
activation through the TCR should provide a means for
detailed analysis [30,31]. These important findings are
not surprising, as antibody-dependent cellular cytotoxic-
ity is inhibited by MHC class I molecules and is mediated
by signal transduction subunits with homology to CD3
components [5]. Inasmuch as B-cell activation involves
a similar cascade [29], it is also noteworthy that trigger-
ing of Fc receptors inhibits activation through surface
immunoglobulin, apparently by activating intracellular
tyrosine phosphatases [32]. Thus, significant progress on
the inhibitory mechanisms of NK-cell receptors and
MHC class I molecules should soon be forthcoming.
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